Tirzepatide vs. Semaglutide: What's the Difference? (2026 Guide)

Tirzepatide vs. Semaglutide: The Core Difference

Tirzepatide (Zepbound for weight loss, Mounjaro for diabetes) and semaglutide (Wegovy for weight loss, Ozempic for diabetes) are both once-weekly injectable medications that reduce appetite and slow digestion — but they work through different mechanisms. Semaglutide acts on a single gut hormone receptor, GLP-1. Tirzepatide acts on two, GLP-1 and GIP. That dual mechanism is the main biological distinction between the two drug classes, and it's the basis for most of the comparisons patients search for.

---

Brand Names Are the Most Common Point of Confusion

Drug	Weight-Loss Brand	Diabetes Brand
Tirzepatide	Zepbound	Mounjaro
Semaglutide	Wegovy	Ozempic

Zepbound and Mounjaro are the same drug, tirzepatide — just approved and marketed under different names for different uses. The same is true of Wegovy and Ozempic for semaglutide. This is why patients researching "is Zepbound tirzepatide" often find conflicting-seeming information: the confusion is about naming, not about two different medications.

---

Do They Work Differently for Weight Loss?

In published clinical trial data, tirzepatide has shown somewhat greater average weight loss compared to semaglutide. This reflects group averages across large trials, not a guarantee for any individual patient — plenty of patients respond very well to semaglutide, and response to either medication varies significantly based on dose, duration, and individual physiology. Neither drug works without the structural pieces around it: appropriate dosing, medical monitoring, and — critically — adequate protein intake and resistance training to preserve muscle mass while losing fat.

---

Side Effects: How Do They Compare?

Both medications share a similar side-effect profile. Nausea, diarrhea, constipation, and occasional vomiting are the most commonly reported side effects for both drugs, particularly during the initial weeks of treatment and after each dose increase. These effects generally ease as the body adjusts to a given dose. Neither medication is clearly better tolerated across the board — individual tolerance tends to vary more from patient to patient than it does between the two drugs on average.

---

How Is Tirzepatide Dosed?

Tirzepatide follows a gradual dose-titration schedule, starting at a low dose and increasing over several weeks as tolerated — standard practice for this drug class, designed to improve tolerability rather than jump straight to a therapeutic dose. The exact schedule, pace of increases, and target maintenance dose are determined by your prescriber based on your response and side effects. This is general educational information about how the drug class works, not a personalized dosing recommendation — your specific plan should come from your prescribing provider.

---

Compounded vs. Brand-Name: What to Know

Compounding of both tirzepatide and semaglutide was permitted in bulk during a period when the FDA had declared both drugs in shortage — that period has ended, and compounded availability is significantly more restricted now than it was even a year or two ago. The shortage-based enforcement discretion ended in 2025 (tirzepatide in March, semaglutide in April) once both became consistently available commercially, and in April 2026 the FDA proposed removing both from the list of substances outsourcing facilities can compound in bulk at all. If a clinic is offering a compounded option, ask directly how they're legally sourcing it under the current rules — don't assume it works the way it did during the shortage years. For our broader breakdown of what separates a legitimate Bay Area GLP-1 program from a prescription mill, see our GLP-1 program guide.